(Q51484171)

5 April 2018

title

Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties. (English)

1 reference

5 April 2018

author name string

Bertucci C

1

1 reference

5 April 2018

Nanni B

2

1 reference

5 April 2018

Raffaelli A

3

1 reference

5 April 2018

Salvadori P

4

1 reference

5 April 2018

publication date

1 October 1998

1 reference

5 April 2018

number of pages

10

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

5 April 2018

volume

18

1 reference

5 April 2018

issue

1-2

1 reference

5 April 2018

page(s)

127-136

1 reference

5 April 2018

Human serum albumin as a 'silent receptor' for drugs and endogenous substances

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

The location of drug binding sites in human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Atomic structure and chemistry of human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Glycosylation of serum albumin: Elevated glycosyl-albumin in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Nonenzymatic glucosylation of lysine residues in albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Presidential message. The need to re-evaluate acetylsalicylic acid (aspirin)

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Protein binding investigation by difference circular dichroism: native and acetylated human serum albumins.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Covalent binding between bucillamine derivatives and human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Improved chromatographic performance of a modified human albumin based stationary phase

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Mode of interaction of loop diuretics with human serum albumin and characterization of binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Two-dimensional electrophoresis of human serum proteins modified by ampicillin during therapeutic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Drug-protein conjugation and its immunological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Stability of phage T4 lysozymes. I. Native properties and thermal stability of wild type and two mutant lysozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Computed circular dichroism spectra for the evaluation of protein conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Competitive binding of two drugs for a single binding site on albumin: a circular dichroic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

Determination of binding constants from continuous circular dichroism titration data by numerical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900163-0

7 January 2021

10.1016/S0731-7085(98)00163-0

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018